Teladoc Health (NYSE:TDOC) Announces Earnings Results, Misses Expectations By $0.02 EPS

→ Trump is sounding the alarm (From Preserve Gold) (Ad)

Teladoc Health (NYSE:TDOC - Get Free Report) released its quarterly earnings results on Thursday. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02), Briefing.com reports. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm had revenue of $646.13 million for the quarter, compared to analysts' expectations of $637.31 million. During the same period in the previous year, the company posted ($0.37) earnings per share. The business's quarterly revenue was up 2.7% compared to the same quarter last year.

Teladoc Health Stock Performance

NYSE TDOC traded down $0.32 on Friday, reaching $13.01. 7,695,552 shares of the company's stock traded hands, compared to its average volume of 4,798,968. The stock has a 50 day moving average price of $15.01 and a 200-day moving average price of $17.77. The firm has a market cap of $2.20 billion, a price-to-earnings ratio of -9.71 and a beta of 0.94. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. Teladoc Health has a fifty-two week low of $12.65 and a fifty-two week high of $30.41.

Insiders Place Their Bets

In related news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Teladoc Health news, CAO Richard J. Napolitano sold 3,765 shares of the company's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the completion of the transaction, the chief accounting officer now owns 18,077 shares in the company, valued at $262,478.04. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Andrew Turitz sold 6,190 shares of the firm's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The disclosure for this sale can be found here. In the last three months, insiders have sold 135,441 shares of company stock valued at $2,038,251. Company insiders own 1.63% of the company's stock.


Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Citigroup reduced their price target on Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 21st. SVB Leerink began coverage on Teladoc Health in a report on Monday, February 26th. They issued a "market perform" rating and a $17.00 price target for the company. Piper Sandler dropped their price target on Teladoc Health from $30.00 to $25.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 21st. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $25.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday. Finally, TD Cowen lowered their target price on shares of Teladoc Health from $16.00 to $15.00 and set a "hold" rating for the company in a research note on Friday. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, Teladoc Health has an average rating of "Hold" and an average price target of $19.67.

Get Our Latest Stock Report on TDOC

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Earnings History for Teladoc Health (NYSE:TDOC)

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Featured Articles and Offers

Search Headlines: